AU658197B2 - New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives - Google Patents

New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives

Info

Publication number
AU658197B2
AU658197B2 AU19381/92A AU1938192A AU658197B2 AU 658197 B2 AU658197 B2 AU 658197B2 AU 19381/92 A AU19381/92 A AU 19381/92A AU 1938192 A AU1938192 A AU 1938192A AU 658197 B2 AU658197 B2 AU 658197B2
Authority
AU
Australia
Prior art keywords
benzimidazoline
oxo
carboxylic acid
acid derivatives
new use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19381/92A
Other versions
AU1938192A (en
Inventor
Franco Dr. Borsini
Alessandro Dr. Brambilla
Herbert Dr. Ladinsky
Pierino Dr. Schiantarelli
Marco Dr. Turconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Italia SpA
Original Assignee
Boehringer Ingelheim Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia SpA filed Critical Boehringer Ingelheim Italia SpA
Publication of AU1938192A publication Critical patent/AU1938192A/en
Application granted granted Critical
Publication of AU658197B2 publication Critical patent/AU658197B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives and physiologically acceptable acid addition salts and solvates thereof in the treatment of organic mental diseases, as for example dementia and amnestic syndromes. Pharmaceutical compositions containing them are also described.
AU19381/92A 1991-07-04 1992-07-02 New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives Ceased AU658197B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI91A1845 1991-07-04
ITMI911845A IT1250629B (en) 1991-07-04 1991-07-04 USE OF BENZIMIDAZOLIN-2-OXO-1-CARBOXYLIC ACID DERIVATIVES.

Publications (2)

Publication Number Publication Date
AU1938192A AU1938192A (en) 1993-01-07
AU658197B2 true AU658197B2 (en) 1995-04-06

Family

ID=11360276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19381/92A Ceased AU658197B2 (en) 1991-07-04 1992-07-02 New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives

Country Status (17)

Country Link
EP (1) EP0523013B1 (en)
JP (1) JPH05194216A (en)
KR (1) KR930001906A (en)
AT (1) ATE115857T1 (en)
AU (1) AU658197B2 (en)
CA (1) CA2072911A1 (en)
DE (1) DE69200948T2 (en)
DK (1) DK0523013T3 (en)
GR (1) GR3015413T3 (en)
HU (2) HUT61462A (en)
IE (1) IE922174A1 (en)
IL (1) IL102381A0 (en)
IT (1) IT1250629B (en)
MX (1) MX9203900A (en)
NO (1) NO922635L (en)
TW (1) TW202386B (en)
ZA (1) ZA924949B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310732A (en) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp Cinnoline-3-carboxylic acid derivative
JP2699794B2 (en) * 1992-03-12 1998-01-19 三菱化学株式会社 Thieno [3,2-b] pyridine derivative
AU1734401A (en) * 1999-12-09 2001-06-18 Mitsubishi Pharma Corporation Carboxyamido derivatives
CA2601458C (en) 2005-03-15 2011-04-26 Pfizer Inc. Benzimidazolone derivatives as cb2 receptor ligands

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190920A2 (en) * 1985-02-04 1986-08-13 Synthelabo Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)azabicycloalkanes
EP0279990A2 (en) * 1986-12-17 1988-08-31 Glaxo Group Limited Use of heterocyclic derivatives in the treatment of cognitive disorders
AU610043B2 (en) * 1988-09-06 1991-05-09 Amsted Industries Incorporated Rope with fiber core and method of forming same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231413B (en) * 1987-09-23 1991-12-04 Angeli Inst Spa BENZIMIDAZOLIN-2-BONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190920A2 (en) * 1985-02-04 1986-08-13 Synthelabo Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)azabicycloalkanes
EP0279990A2 (en) * 1986-12-17 1988-08-31 Glaxo Group Limited Use of heterocyclic derivatives in the treatment of cognitive disorders
AU610043B2 (en) * 1988-09-06 1991-05-09 Amsted Industries Incorporated Rope with fiber core and method of forming same

Also Published As

Publication number Publication date
ITMI911845A1 (en) 1993-01-05
TW202386B (en) 1993-03-21
IL102381A0 (en) 1993-01-14
JPH05194216A (en) 1993-08-03
KR930001906A (en) 1993-02-22
IT1250629B (en) 1995-04-21
HUT61462A (en) 1993-01-28
NO922635D0 (en) 1992-07-03
HU9202229D0 (en) 1992-10-28
EP0523013A2 (en) 1993-01-13
CA2072911A1 (en) 1993-01-05
DE69200948D1 (en) 1995-02-02
GR3015413T3 (en) 1995-06-30
ATE115857T1 (en) 1995-01-15
AU1938192A (en) 1993-01-07
HU211855A9 (en) 1995-12-28
DK0523013T3 (en) 1995-05-08
NO922635L (en) 1993-01-05
MX9203900A (en) 1993-01-01
ITMI911845A0 (en) 1991-07-04
EP0523013B1 (en) 1994-12-21
DE69200948T2 (en) 1995-05-18
ZA924949B (en) 1994-01-03
IE922174A1 (en) 1993-01-13
EP0523013A3 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
AU637086B2 (en) Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions
NZ240936A (en) Alkoxy-substituted 1-phenyl-isoquinoline derivative and pharmaceutical compositions
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
IL109578A0 (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
ZA885192B (en) Pharmaceutical preparations
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
ZA884919B (en) 3-demethylmevalonic acid derivatives,a process for their preparation,pharmaceutical products based on these compounds,their use and intermediates
CA2076589A1 (en) Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
EP0535250A4 (en) Novel compounds and use thereof as medicine
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
CA2003981A1 (en) Pharmaceutical compositions and use thereof in the treatment of psoriasis
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
NZ223333A (en) 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions
NO163283C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-BICYCLOHEPTYL AND N-BICYCLOHEPTENYLIMIDAZOLES.